BackTable / VI / Podcast / Episode #543

Metastatic Colorectal Cancer: Discussion on the COLLISION Trial

with Dr. Martijn Meijerink

Is minimally invasive ablation the future of metastatic cancer care? We now have the results of the COLLISION Trial, which investigates the non-inferiority of thermal ablation compared to surgical resection. How will these findings change treatment paradigms and practice patterns around metastatic colorectal cancer? In this week’s episode of BackTable, interventional radiologist Dr. Chris Beck discusses the impact and implications of the COLLISION Trial with principal investigator Dr. Martijn Meijerink from Amsterdam UMC.

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Metastatic Colorectal Cancer: Discussion on the COLLISION Trial with Dr. Martijn Meijerink on the BackTable VI Podcast

Ep 543 Metastatic Colorectal Cancer: Discussion on the COLLISION Trial with Dr. Martijn Meijerink

00:00 / 01:04

BackTable, LLC (Producer). (2025, May 13). Ep. 543 – Metastatic Colorectal Cancer: Discussion on the COLLISION Trial [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Podcast Contributors

Dr. Christopher Beck

Dr. Chris Beck is a practicing interventional radiologist with Regional Radiology Group in New Orleans.

Dr. Martijn Meijerink

Dr. Martijn Meijerink is an interventional radiologist and primary investigator of the COLLISION Trial at UMC Amsterdam.

Synopsis

The doctors explore the COLLISION Trial’s design, results, complication rates, and future directions. They also cover best practices for ablation techniques and the potential for interventional oncology to enter a “golden era.” Finally, Dr. Meijerink highlights the importance of standardizing intervention quality and being present in tumor boards to ensure optimal patient care.

Timestamps

00:00 - Introduction
03:21 - Understanding Metastatic Colorectal Cancer and IR’s Role
05:18 - Introduction to the COLLISION Trial
07:40 - Radiofrequency vs Microwave Ablation and Technological Advancements
09:02 - Trial Design and Patient Eligibility
16:20 - Ablation Techniques and Approaches
22:05 - Trial Results and Analysis
30:19 - Impact on Guidelines and Practice
39:44 - Best Practices in Thermal Ablation
43:27 - Future Directions in Interventional Oncology

Resources

Surgery versus thermal ablation for small-size colorectal liver metastases (COLLISION): An international, multicenter, phase III randomized controlled trial (Meijerink, 2024)
https://ascopubs.org/doi/10.1200/JCO.2024.42.17_suppl.LBA3501

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Up Next

Comparing Thermal Ablation Techniques for Liver Lesions with Dr. Jason Hoffmann on the BackTable VI Podcast

NSCLC Tumor Board Discussion: Considerations for Oligometastatic Disease with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh and Dr. Alan Lee on the BackTable VI Podcast

Microwave Ablation for Liver Tumors: Techniques & Outcomes with Dr. Driss Raissi on the BackTable VI Podcast

Winding Down Neuwave: Impact on Interventional Radiology with Dr. Josh Kuban on the BackTable VI Podcast

Approach to Microwave Liver Ablations with Dr. Asad Baig on the BackTable VI Podcast

Multidisciplinary HCC Care: Improving the Patient Experience with Combined Clinics with Dr. Tyler Sandow, Dr. Jonathan Mizrahi, Dr. Steven Young and Deondra Bonds-Adams on the BackTable VI Podcast

Articles

Topics

Metastatic Colorectal Cancer (mCRC) Podcasts

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.